DEA Reviews Myonex LLC Application for Importing Controlled Substances
April 18, 2025
April 18, 2025
WASHINGTON, April 18 (TNSFR) -- The U.S. Department of Justice Drug Enforcement Administration (DEA) has announced that Myonex LLC, located at 100 Progress Drive, Horsham, Pennsylvania, has applied to be registered as an importer of several Schedule II controlled substances.
This application, submitted on January 9, 2025, seeks permission to import substances such as Amphetamine, Lisdexamfetamine, Methylphenidate, Nabilone, Oxycodone, Hydromorphone, Hydrocodone, Morphine, Oxymorpho . . .
This application, submitted on January 9, 2025, seeks permission to import substances such as Amphetamine, Lisdexamfetamine, Methylphenidate, Nabilone, Oxycodone, Hydromorphone, Hydrocodone, Morphine, Oxymorpho . . .